Ciudo, Fritsyl Mar .
HRN: 23-12-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2023
CO-AMOXICLAV 625MG (TAB)
05/30/2023
06/05/2023
PO
625
Bid
Thickly Meconium Stained
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes